Deuterium Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	0	–	–	–	58
2023 Q4	–	Hold	0	–	–	–	52
2023 Q2	–	Sell	-51,256	Closed	-$159K	–	103
2023 Q1	$159K	Buy	+51,256	New	+$159K	0.25%	68